UCP3 is a mitochondrial protein with high homology to the established uncoupling protein, UCP1. Its high degree of homology to UCP1 suggests that UCP3 may be a true uncoupling protein. Preliminary biochemical studies are consistent with UCP3 having uncoupling activity. However, detailed functional studies are required to understand the true biochemical and physiological purpose of UCP3. These efforts should be aided by identi®cation of humans with inactivating mutations andaor the generation of gene knockout mice lacking UCP3.
Introduction
Uncoupling protein-1 (UCP1) is a brown fat-speci®c, mitochondrial inner membrane protein with proton transport activity. This activity uncouples fuel consumption from the conversion of ADP to ATP, thereby releasing stored energy as heat. In rodents, UCP1 activity and brown fat contribute importantly to whole body energy expenditure. In humans, however, brown fat is less abundant, and may not play a signi®cant role in regulating energy balance. Recently, two additional mitochondrial carriers with high homology to UCP1 were molecularly cloned. In contrast with UCP1, UCP2 is expressed widely and UCP3 is expressed preferentially in skeletal muscle. Preliminary studies suggest that UCP3, like UCP1, has uncoupling activity. This continues to be an active area of investigation. If UCP3 is a genuine uncoupling protein, then it is likely to be an important regulator of energy metabolism in humans.
Molecular cloning of UCP3 and predictions of function based on sequence homology UCP3 was molecularly cloned initially by Boss et al, 1 and then shortly thereafter by Vidal-Puig et al 2 and Gong et al.
3 UCP3 is highly homologous to UCP1 ( 57% identical at the amino acid level) and UCP2 ( 71% identical at the amino acid level). UCP3 is much less homologous to other members of the mitochondrial carrier super family: oxoglutarate carrier ( 32% identical), citrate carrier ( 25% identical), carnitine carrier ( 25% identical), phosphate carrier (`25% identical) and ADPaATP carrier (`25% identical). Based upon the high homology of UCP3 with UCP1, compared to its lower homology with other members of the mitochondrial carrier family, it is predicted that UCP3 shares biochemical functions with UCP1, including uncoupling activity.
In support of this view, it has been shown that UCP3, like UCP1, decreases mitochondrial membrane potential when expressed in yeast 3 and mammalian 4 cells. In contrast with this view, it has recently been shown by Bienengraeber et al 5 that simultaneous mutation of histidine residues H145 and H147 in UCP1 destroys proton transport activity as assessed using a reconstituted proteoliposome system. Mutation of only one of these histidine residues in UCP1 decreases proton transport activity by 90%. Of note, both histidines are absent from mouse and rat UCP3, and human UCP3 lacks the equivalent histidine, H145. Similarly, UCP2 lacks both histidine residues. This ®nding raises two possibilities: either UCP2 and UCP3 do not transport protons or their mechanism of proton transport is different from that utilized by UCP1.
It should be noted that the mitochondrial carrier family in mammals has additional members of known function which have yet to be molecularly cloned. These include the dicarboxylate carrier, the ornithine carrier, the pyruvate carrier and the aspartatea glutamate carrier. 6 These carriers have been biochemically puri®ed and studied in vitro using reconstituted proteoliposome systems. Since these carriers have not been molecularly cloned, and the precise biochemical function of UCP3 has yet to be established, it is formally possible that UCP3 represents one of these carriers.
UCP3 mRNA expression
UCP3 is expressed abundantly and preferentially in skeletal muscle in humans and rodents 1 ± 3 and in brown fat in rodents 1 ± 3 but not humans. 1 UCP3 expression in muscle is markedly upregulated by starvation. 3 The purpose of starvation-induced upregulation of UCP3 is unknown, and con¯icts with the notion that UCP3 positively regulates systemic energy expenditure, as energy expenditure decreases during starvation. It has been suggested that the starvationinduced increase in UCP3 is caused by elevated free fatty acids and somehow plays an important role in their metabolism. 7 This is an attractive hypothesis in that muscle is a major site of free fatty acid metabolism, especially during starvation. However, as of yet there is no clear view regarding the role of UCP3 in free fatty acid metabolism.
UCP3 short form transcript
Unlike UCP1 and UCP2, human UCP3 mRNA exists as short and long-form transcripts, UCP3 S and UCP3 L .
18 UCP3 S is predicted to encode a protein which lacks the last 37 C-terminal residues of UCP3 L . It has previously been established that UCP1 has six transmembrane domains. 9 Based upon homology of UCP3 to UCP1, UCP3 S should lack most of the 6th transmembrane domain as well as Cterminal sequence. The corresponding region in UCP1, absent in UCP3 S , is thought to participate in purine nucleotide binding 10, 11 which inhibits UCP1 uncoupling activity, therefore raising the possibility that UCP3 S has increased activity. Alternatively, it is possible that mature UCP3 S protein is unstable and does not exist. In summary, it is presently unknown whether UCP3 S exists as a mature protein, andaor whether its activity is increased or decreased with respect to UCP3 L .
UCP3 gene structure and basis for short form transcript
The human UCP3 gene consists of seven exons spanning 8.5 kb and is located on chromosome 11 (11q13), adjacent to UCP2. 8, 12 UCP3 S transcript is generated when a cleavage and polyadenylation signal (AATAAA) located in intron 6 prematurely terminates message elongation (Figure 1 ). The 37 residues missing from UCP3 S are encoded by exon 7. Of interest, a mutation in the ®rst base pair of the intron between exon 6 and 7 has been identi®ed. 13 This mutation destroys the splice donor site, preventing UCP3 L from being generated. Consequently, this allele can only generate UCP3 S . It was reported that individuals heterozygous for this mutation have normal body weight. However, basal fatty acid oxidation was reduced by 50% and respiratory quotient was markedly increased in these individuals. 13 These ®nd-ings are consistent with the view that UCP3 S has decreased activity and that UCP3 plays an important role in free fatty acid metabolism. However, a more detailed analysis of individuals with this mutations, as well as a determination of functional properties of UCP3 S vs UCP3 L protein is required to fully understand the signi®cance of these observations. 8 Exons are coded from 1 ± 7. 3 0 untranslated regions for UCP3 S and UCP3 L are shown as UTR S and UTR L , respectively. Schematic cDNAs are shown below the gene structure. On the bottom is the exact location of the splice donors and splice acceptors (large case letters refer to exon sequence, small case letters refer to intron sequence). Amino acids adjacent to the splice sites are shown below the nucleotide sequence.
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